510(k) Report

510(k) · Cleared

Cleared

Acetaminophen Assay for the Advia Integrated Modular System

K020792510(k) TraditionalCleared Jul 11, 2002122-day reviewClass II21 CFR 862.3030

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bayer Diagnostics Corp. · LDP Colorimetry, Acetaminophen

Cleared on Jul 11, 2002 as substantially equivalent to K840941 (Abbott Laboratories, 1984) after a 122-day review. Its family tree reaches back 1 generation to 1984.

Decided
Jul 11, 2002
Review
122 days
Class
Class II
Product code
LDP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K840941 (1984). No later device cites it as a predicate yet.

K840941 · TDX Acetaminophen · Abbott Laboratories · 198419801985199019952000
K840941 · TDX Acetaminophen · Abbott Laboratories · 19840
  1. Root · 1 generation backK840941 TDX AcetaminophenAbbott Laboratories · 1984
  2. This deviceK020792 Acetaminophen Assay for the Advia Integrated Modular SystemBayer Diagnostics Corp. · 2002
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K840941TDX AcetaminophenAbbott Laboratories1984—
0 (this device)K020792Acetaminophen Assay for the Advia Integrated Modular SystemBayer Diagnostics Corp.2002—
FIG. 1 — Lineage of K020792, 1984–2002Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LDP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LDP device

  1. #1 K261364 Atellica CH Acetaminophen 2 (ACTM)score 11.7 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K840941TDX Acetaminophen
Summary page 2
…rformance of the ADVIA IMS Acetaminophen Assay on a Bayer ADVIA@ IMSTMis equivalent to the performance of the Acetaminophen Assay on the predicate device (Abbott TDX, K840941) and is w i h proposed manufacturing specifications. No safety and effectiveness issues have been raised.…
Abbott Laboratories1984—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All LDP devices

LDP Colorimetry, Acetaminophen: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LDP

1in 2022

2009: 12010: 12011: 12019: 12022: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LDP

Too few LDP 510(k)s in any year since 2007 to give a median.

Recalls per year · LDP

1in 2013

2007: 12008: 12010: 22013: 1
2007high 2 (2010) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LDP

3in 2025

2007: 62008: 22009: 12010: 52011: 52012: 22013: 42014: 22015: 12016: 12017: 32021: 22023: 12024: 12025: 3
2007high 6 (2007) · low 0 (2018)2025

MAUDE reports naming product code LDP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—16
20080—12
20091—01
20101—25
20111—05
20120—02
20130—14
20140—02
20150—01
20160—01
20170—03
20180—00
20191—00
20200—00
20210—02
20221—00
20230—01
20240—01
20250—03
20261—0—

What is it indicated for?

The Buyer ADC24 M S Acetaminophen method is an in vitro diagnostic device intended to measure acetaminophen levels in human serum or plasma (Lithium heparin). Such measurements are used in the diagnosis of acetaminophen toxicity and overdose.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K020792: Acetaminophen Assay for the Advia Integrated Modular System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K020792

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026